SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-20-000562
Filing Date
2020-07-24
Accepted
2020-07-23 18:07:27
Documents
3
Period of Report
2020-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k072220_8k.htm 8-K 15722
2 EXHIBIT 3.1 AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF THE COMPANY f8k072220_ex3z1.htm EX-3.1 7870
3 IMAGE f8k0722208k_1.jpg GRAPHIC 51378
  Complete submission text file 0001078782-20-000562.txt   95360
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 201044650
SIC: 2834 Pharmaceutical Preparations